Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDV/SOF and SOF+RBV in HCV with Bleeding Disorders
NCT02120300Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ledipasvir, sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Apr 2014; status: completed.
02
Drugs
ledipasvirsofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02120300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120300.